BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 10, 2015
View Archived Issues
Daiichi Sankyo advances pipeline in first quarter of fiscal 2015
Read More
Simulation-guided DNA probes designed to improve specificity of NA hybridization
Read More
MedImmune and Amgen start phase IIa trial of AMG-557 in Sjogren's syndrome
Read More
Sunshine Lake Pharma develops FXa inhibitors
Read More
Wockhardt divulges beta-lactamase inhibitors
Read More
Euclises Pharmaceuticals designs COX-2 inhibitors/NO donors
Read More
4D Pharma and APC Microbiome Institute to investigate live biotherapeutics for autism
Read More
Kwang Dong licenses South Korean rights to Contrave
Read More
Ono Pharmaceutical reviews events of first quarter of fiscal 2015
Read More
Celsion provides update on phase III trials of ThermoDox in HCC
Read More
LSK BioPharma in-licenses BTK inhibitor HCI-1401
Read More
Preclinical evidence that ET-B receptor agonism slows Alzheimer’s Disease progression
Read More
Hetero launches biosimilar rituximab in India
Read More
Antisense therapy proved effective in reducing triglyceride levels
Read More
Cold Genesys secures funding for immunotherapy trials
Read More
Sanofi and Evotec to collaborate on beta-cell-targeting therapies for diabetes
Read More
Dr. Reddy's to market three Amgen products in India
Read More
AstraZeneca discloses DPP1 inhibitors
Read More
Sunshine Lake patents HCV NS5A inhibitors
Read More
Cellceutix begins phase II trial of Prurisol for psoriasis
Read More
Lundbeck joins Global Alzheimer's Platform
Read More
Antiva Biosciences raises funds to advance lead compound for HPV
Read More
Allergan starts phase I trial of dry eye candidate AGN-232411
Read More
Varlitinib receives orphan drug designation from the FDA for cholangiocarcinoma
Read More
The FDA grants orphan drug designation to daratumumab for follicular lymphoma
Read More
New York State grants conditional approval for Rosetta Genomics' lung biomarker
Read More